BLATT LAWRENCE

President and CEO at Aligos Therapeutics, Inc. · on record since Oct 20, 2020
Frmr Chief Scientific Officer at INTERMUNE INC · on record since May 21, 2008
Director at Aligos Therapeutics, Inc. · on record since Oct 15, 2020
SVP - Preclinical at INTERMUNE INC · on record since Jun 27, 2005

Insider trading activity of BLATT LAWRENCE

Transactions on record: 70; since Apr 5, 2004

Open-market buys: 0

Open-market sells: 12; $1M

Companies traded: 2; last filing Mar 11, 2026

Figures computed from official regulatory filings — methodology.

Companies where BLATT LAWRENCE has traded

Aligos Therapeutics, Inc.39 tx · $503.5K · Mar 11, 2026
INTERMUNE INC31 tx · $1.5M · May 21, 2008

Track record of BLATT LAWRENCE

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BLATT LAWRENCE

Co-insiders of BLATT LAWRENCE

Achneck HardeanAligos Therapeutics, Inc.
Aneja NikhilAligos Therapeutics, Inc.
ARATA PAUL DINTERMUNE INC
ARMSTRONG MARIANNEINTERMUNE INC
BARBARI SHARON SURREYINTERMUNE INC
Beigelman LeonidAligos Therapeutics, Inc.
BIENAIME JEAN JACQUESINTERMUNE INC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Aligos Therapeutics, Inc.	Mar 11, 2026	AwardD	105,840	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Jul 18, 2025	AwardD	179,800	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 4, 2025	AwardD	140,103	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Sep 6, 2024	AwardD	33,920	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 4, 2024	AwardD	965,435	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-80,850	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	57,749	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	230,999	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-450,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-323,400	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	132,352	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 27, 2023	AwardD	305,138	0.13 USD	$39.7K	SEC
Aligos Therapeutics, Inc.	Oct 27, 2023	Award	610,277	0.76 USD	$463.8K	SEC
Aligos Therapeutics, Inc.	Sep 12, 2023	AwardD	150,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 17, 2023	AwardD	242,500	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Jul 11, 2022	AwardD	161,700	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 8, 2022	AwardD	80,850	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 8, 2022	AwardD	323,400	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Dec 3, 2020	AwardD	450,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	50,712	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	OtherD	-13,671	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	13,671	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	OtherD	-13,671	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	41,016	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	1,452	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Aligos Therapeutics, Inc.	Mar 11, 2026	AwardD	105,840	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Jul 18, 2025	AwardD	179,800	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 4, 2025	AwardD	140,103	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Sep 6, 2024	AwardD	33,920	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 4, 2024	AwardD	965,435	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-80,850	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	57,749	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	230,999	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-450,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	OtherD	-323,400	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 28, 2024	AwardD	132,352	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 27, 2023	AwardD	305,138	0.13 USD	$39.7K	SEC
Aligos Therapeutics, Inc.	Oct 27, 2023	Award	610,277	0.76 USD	$463.8K	SEC
Aligos Therapeutics, Inc.	Sep 12, 2023	AwardD	150,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Mar 17, 2023	AwardD	242,500	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Jul 11, 2022	AwardD	161,700	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 8, 2022	AwardD	80,850	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Feb 8, 2022	AwardD	323,400	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Dec 3, 2020	AwardD	450,000	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	50,712	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	OtherD	-13,671	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	13,671	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	OtherD	-13,671	0.00 USD	$0	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	41,016	—	—	SEC
Aligos Therapeutics, Inc.	Oct 20, 2020	Other	1,452	—	—	SEC